Vascular Graft Market is anticipated to register notable growth through 2032, owing to the increasing cases of chronic kidney diseases in developing countries. According to credible reports, chronic kidney disease impacts more than 10% (approximately over 800 million individuals) of the general population worldwide.
In addition, constant innovations in the vascular grafts will further support market growth. Citing an instance, researchers from the University of Waterloo, in 2022, devised a method of modifying synthetic vascular grafts from seaweed. The seaweed material, fucoidan, is anticipated to offer better bypass surgery outcomes.
Overall, the vascular graft industry is segmented in terms of raw material, application, end-user, and region.
Considering the raw material, the polyester graft market is anticipated to garner potential gains by 2032 end. The increasing adoption of polyester grafts across healthcare facilities would support the segment growth. Besides, high patency, longer lifespan, and easy accessibility are among the key benefits offered by polyester grafts, which will further increase its adoption in the foreseeable future.
Based on application, the hemodialysis access segment is anticipated to depict over 7% CAGR through 2032. The segmental growth can be credited to the increasing incidences of ESRD (end-stage renal disease) and the rising burden of CKD (chronic kidney disease). One of the prominently used vascular grafts for hemodialysis is an arteriovenous (AV) graft. Some of the advantages offered by these include solution for weak or small veins and ability to be used within 2-4 weeks after placement. Moreover, the AV graft surgery is done on an outpatient basis, enabling easy and faster recovery period. In addition, the rising adoption of minimally invasive procedures is further anticipated to drive the demand for hemodialysis access.
By end-use, the others segment accounted for USD 337.5 million revenue share in 2022. The others segment includes academic hospitals and research institutes. Increasing R&D and investment in offering the best treatments across these end-user organizations will significantly impact segmental expansion in the coming years.
Regionally, the North America vascular graft industry will grow considerably between 2023-2032. The regional market growth is anticipated to come from constantly increasing cases of cardiac disorders. As per CDC estimates, one person succumbs to death in every 34 seconds in the United States from CVDs. In addition, sedentary lifestyles, unhealthy eating habits, and alcohol abuse will play a key role in raising the number of vascular disease cases. The increasing adoption of novel and innovative vascular grafts for treating aortic aneurysms and the vascular bypass will further positively influence the overall regional expansion.